131 related articles for article (PubMed ID: 29098933)
1. Association between monocyte chemoattractant protein-1 and blood pressure in smokers.
Komiyama M; Takanabe R; Ono K; Shimada S; Wada H; Yamakage H; Satoh-Asahara N; Morimoto T; Shimatsu A; Takahashi Y; Hasegawa K
J Int Med Res; 2018 Mar; 46(3):965-974. PubMed ID: 29098933
[TBL] [Abstract][Full Text] [Related]
2. Association of HIV viral load with monocyte chemoattractant protein-1 and atherosclerosis burden measured by magnetic resonance imaging.
Floris-Moore M; Fayad ZA; Berman JW; Mani V; Schoenbaum EE; Klein RS; Weinshelbaum KB; Fuster V; Howard AA; Lo Y; Schecter AD
AIDS; 2009 May; 23(8):941-9. PubMed ID: 19318907
[TBL] [Abstract][Full Text] [Related]
3. Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients.
Takebayashi K; Matsumoto S; Aso Y; Inukai T
J Diabetes Complications; 2006; 20(2):98-104. PubMed ID: 16504838
[TBL] [Abstract][Full Text] [Related]
4. Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis.
Deo R; Khera A; McGuire DK; Murphy SA; Meo Neto Jde P; Morrow DA; de Lemos JA
J Am Coll Cardiol; 2004 Nov; 44(9):1812-8. PubMed ID: 15519012
[TBL] [Abstract][Full Text] [Related]
5. Cigarette smoking affects microRNAs and inflammatory biomarkers in healthy individuals and an association to single nucleotide polymorphisms is indicated.
Andersson BÅ; Sayardoust S; Löfgren S; Rutqvist LE; Laytragoon-Lewin N
Biomarkers; 2019 Mar; 24(2):180-185. PubMed ID: 30375257
[TBL] [Abstract][Full Text] [Related]
6. Plasma monocyte chemoattractant protein-1 as risk marker in type 2 diabetes mellitus and coronary artery disease in North Indians.
Harsimran K; Singh AA; Guruvinder S; Sharda S; Vasudha S
Diab Vasc Dis Res; 2009 Oct; 6(4):288-90. PubMed ID: 20368224
[TBL] [Abstract][Full Text] [Related]
7. Increased levels of serum and gingival crevicular fluid monocyte chemoattractant protein-1 in smokers with periodontitis.
Anil S; Preethanath RS; Alasqah M; Mokeem SA; Anand PS
J Periodontol; 2013 Sep; 84(9):e23-8. PubMed ID: 23368946
[TBL] [Abstract][Full Text] [Related]
8. Monocyte chemoattractant protein-1 is related to metabolic syndrome and homocysteine in subjects without clinically significant atherosclerotic cardiovascular disease.
Kim SH; Lee JW; Im JA; Hwang HJ
Scand J Clin Lab Invest; 2011 Feb; 71(1):1-6. PubMed ID: 21073393
[TBL] [Abstract][Full Text] [Related]
9. Monocyte chemoattractant protein-1 gene polymorphism and its serum level have an impact on anthropometric and biochemical risk factors of metabolic syndrome in Indian population.
Madeshiya AK; Singh S; Dwivedi S; Saini KS; Singh R; Tiwari S; Konwar R; Ghatak A
Int J Immunogenet; 2015 Apr; 42(2):78-86. PubMed ID: 25639755
[TBL] [Abstract][Full Text] [Related]
10. Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease.
Martinovic I; Abegunewardene N; Seul M; Vosseler M; Horstick G; Buerke M; Darius H; Lindemann S
Circ J; 2005 Dec; 69(12):1484-9. PubMed ID: 16308496
[TBL] [Abstract][Full Text] [Related]
11. Deregulated expression of monocyte chemoattractant protein-1 (MCP-1) in arterial hypertension: role in endothelial inflammation and atheromasia.
Tucci M; Quatraro C; Frassanito MA; Silvestris F
J Hypertens; 2006 Jul; 24(7):1307-18. PubMed ID: 16794480
[TBL] [Abstract][Full Text] [Related]
12. Significance of the level of monocyte chemoattractant protein-1 in human atherosclerosis.
Kusano KF; Nakamura K; Kusano H; Nishii N; Banba K; Ikeda T; Hashimoto K; Yamamoto M; Fujio H; Miura A; Ohta K; Morita H; Saito H; Emori T; Nakamura Y; Kusano I; Ohe T
Circ J; 2004 Jul; 68(7):671-6. PubMed ID: 15226634
[TBL] [Abstract][Full Text] [Related]
13. Correlation between serum biomarkers and BODE index in patients with stable COPD.
Liu SF; Chin CH; Wang CC; Lin MC
Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
[TBL] [Abstract][Full Text] [Related]
14. Monocyte chemoattractant protein-1 in patients with peripheral arterial disease.
Petrkova J; Szotkowska J; Hermanova Z; Lukl J; Petrek M
Mediators Inflamm; 2004 Feb; 13(1):39-43. PubMed ID: 15203564
[TBL] [Abstract][Full Text] [Related]
15. Cigarette Smoking and Longitudinal Associations With Blood Pressure: The CARDIA Study.
Luehrs RE; Zhang D; Pierce GL; Jacobs DR; Kalhan R; Whitaker KM
J Am Heart Assoc; 2021 May; 10(9):e019566. PubMed ID: 33902307
[TBL] [Abstract][Full Text] [Related]
16. MCP-1 -2518 A/G gene polymorphism is associated with blood pressure in ischemic heart disease asymptomatic subjects.
Penz P; Bucova M; Lietava J; Blazicek P; Paulovicova E; Mrazek F; Bernadic M; Buckingham TA; Petrek M
Bratisl Lek Listy; 2010; 111(8):420-5. PubMed ID: 21033620
[TBL] [Abstract][Full Text] [Related]
17. CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study.
McDermott DH; Yang Q; Kathiresan S; Cupples LA; Massaro JM; Keaney JF; Larson MG; Vasan RS; Hirschhorn JN; O'Donnell CJ; Murphy PM; Benjamin EJ
Circulation; 2005 Aug; 112(8):1113-20. PubMed ID: 16116069
[TBL] [Abstract][Full Text] [Related]
18. [Monocyte chemoattractant protein-1 and its correlation with lipoprotein in polycystic ovary syndrome].
Hu WH; Qiao J; Zhao SY; Zhang XW; Li MZ
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):487-91. PubMed ID: 17068620
[TBL] [Abstract][Full Text] [Related]
19. Increase in circulating levels of monocyte chemoattractant protein-1 with aging.
Inadera H; Egashira K; Takemoto M; Ouchi Y; Matsushima K
J Interferon Cytokine Res; 1999 Oct; 19(10):1179-82. PubMed ID: 10547158
[TBL] [Abstract][Full Text] [Related]
20. Effects of smoking cessation on changes in blood pressure and incidence of hypertension: a 4-year follow-up study.
Lee DH; Ha MH; Kim JR; Jacobs DR
Hypertension; 2001 Feb; 37(2):194-8. PubMed ID: 11230270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
